Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
Publication
, Journal Article
Holman, RR; Sourij, H; Califf, RM
Published in: Lancet
September 20, 2014
Duke Scholars
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
September 20, 2014
Volume
384
Issue
9948
Start / End Page
1097 / 1098
Location
England
Related Subject Headings
- Hypoglycemic Agents
- Humans
- General & Internal Medicine
- Diabetic Angiopathies
- Diabetes Mellitus, Type 2
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holman, R. R., Sourij, H., & Califf, R. M. (2014). Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply. Lancet, 384(9948), 1097–1098. https://doi.org/10.1016/S0140-6736(14)61674-3
Holman, Rury R., Harald Sourij, and Robert M. Califf. “Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.” Lancet 384, no. 9948 (September 20, 2014): 1097–98. https://doi.org/10.1016/S0140-6736(14)61674-3.
Holman RR, Sourij H, Califf RM. Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply. Lancet. 2014 Sep 20;384(9948):1097–8.
Holman, Rury R., et al. “Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.” Lancet, vol. 384, no. 9948, Sept. 2014, pp. 1097–98. Pubmed, doi:10.1016/S0140-6736(14)61674-3.
Holman RR, Sourij H, Califf RM. Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply. Lancet. 2014 Sep 20;384(9948):1097–1098.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
September 20, 2014
Volume
384
Issue
9948
Start / End Page
1097 / 1098
Location
England
Related Subject Headings
- Hypoglycemic Agents
- Humans
- General & Internal Medicine
- Diabetic Angiopathies
- Diabetes Mellitus, Type 2
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences